The Appearance Care Center

The Appearance Care Center, established in 2001 in San Francisco, CA, operates under the medical direction of board-certified facial plastic surgeons holding dual certification from the American Board of Facial Plastic and Reconstructive Surgery and the American Board of Otolaryngology, Head and Neck Surgery. This dual-board certification provides patients with surgical expertise combined with comprehensive aesthetic medicine capabilities, positioning the practice to address both structural and surface-level aging concerns through medical and procedural interventions. The clinic integrates peptide therapy and GLP-1 receptor agonist protocols into its broader aesthetic medicine framework, treating patients seeking non-surgical anti-aging solutions alongside traditional cosmetic procedures in the San Francisco Bay Area.

Peptide therapy at The Appearance Care Center focuses on anti-aging applications, with GLP-1 receptor agonists prescribed for metabolic optimization and weight management as part of comprehensive aesthetic treatment plans. The clinic's approach combines these peptide protocols with established aesthetic treatments including neuromodulators like Botox, dermal fillers, skin resurfacing procedures, and body contouring technologies. This integration allows providers to address aging from multiple physiological angles—metabolic function, skin quality, volume loss, and body composition—rather than treating these concerns in isolation. Patients typically receive peptide therapy as one component of a personalized treatment plan developed after comprehensive aesthetic consultation and medical evaluation.

The medical team's background in facial plastic surgery and otolaryngology provides anatomical expertise that informs both surgical and non-surgical treatment planning. This surgical foundation proves particularly relevant when combining peptide therapies with injectable treatments, as providers apply detailed knowledge of facial anatomy, aging patterns, and tissue behavior when designing protocols. The clinic's longevity in San Francisco since 2001 has allowed its providers to observe long-term aesthetic outcomes across diverse patient populations, informing current treatment approaches and combination therapy strategies. Patients benefit from this experience when providers recommend specific peptide protocols alongside other aesthetic interventions based on individual aging patterns and aesthetic goals.

Patients visiting The Appearance Care Center for peptide therapy undergo in-person consultations at the San Francisco location, where providers conduct medical history review, discuss aesthetic concerns, and perform physical assessment before prescribing GLP-1 or other peptide protocols. The consultation process includes discussion of expected timelines, monitoring requirements, potential side effects, and how peptide therapy integrates with any concurrent aesthetic treatments. Patients receiving GLP-1 for weight management typically follow structured protocols with regular follow-up appointments to assess response, adjust dosing, and monitor for adverse effects. The clinic's focus on facial aesthetics means providers pay particular attention to how weight loss from GLP-1 therapy affects facial volume and skin quality, often coordinating peptide treatment with volumizing procedures or skin tightening technologies to maintain aesthetic balance during body composition changes.

The Appearance Care Center's location in San Francisco provides access to patients throughout the Bay Area seeking medically supervised peptide therapy within an established aesthetic medicine practice. The clinic's structure as a comprehensive aesthetic center means patients can address multiple aging concerns—metabolic, dermal, and structural—within a single practice rather than coordinating care across multiple providers. This integrated approach proves particularly valuable for patients using GLP-1 therapy, as the same medical team managing peptide protocols can simultaneously address aesthetic changes that occur during weight loss, adjusting treatment plans in real-time based on observed outcomes. The practice's two-decade presence in San Francisco has established referral relationships with primary care providers and specialists, facilitating coordinated care when peptide therapy requires collaboration with other medical disciplines.